Kline Blogs Banner

Key Growth Forces in the Chinese HI&I Ingredient Market 

The market of ingredients for household, industrial, and institutional (HI&I) cleaning applications is going through changes across all regions of the world. Innovation in dosage forms, increasing disposable income in developing countries, the growing importance of the green movement, and environmental regulations are some of the key trends driving those changes. Herewith, we are highlighting some insights into the Chinese market from our HI&I study, scheduled to be published in Q4 2020.  

Continue reading

[WEBINAR] ASEAN Lubricants Market – Key Drivers and Trends

Despite a major setback due to the pandemic, the lubricants market in ASEAN region is very dynamic and presents strong growth prospects over the forecast period. Overall, growth is expected to be driven by the consumer segment, followed by the commercial and industrial segments. Government regulations and policies, COVID-19’s impact in the short term, consumer purchasing power, government spending on key industries, and international trade and commodity prices are some of the factors that can critically impact industrial and commercial automotive lubricants segments over the forecast period. Learn about this dynamic market from the upcoming webinar.

Continue reading

Bright Future – Key Factors Driving the Biotechnology Products in Personal Care  

Biotechnology is one of the fastest-growing categories of cosmetics products in the world.  

In the personal care actives industry, the term “biotechnology products” indicates all products manufactured through bioprocesses, which primarily includes products produced with extracts from micro-organisms. Cosmetics companies are gradually adopting these technologies, as they offer better results on topical application and meet consumer demand for high-efficacy and natural products.  Moreover, growing consumer awareness about sustainable sourcing favors the growth of biotechnology actives, which are derived from natural sources. 

Continue reading

The Latest Acquisitions Prove the Biologics Market’s Resistance  

On October 6, 2020, Syngenta Group announced the acquisition of Valagro, a leading biologicals company, by its business unit, Syngenta Crop Protection. This investment positions Syngenta Crop Protection as one of the key global companies poised to shape the rapidly growing biologicals market. This market is expected to nearly double in size over the next five years. Valagro will continue to operate as an independent brand in the market within the Syngenta Crop Protection business.

Continue reading

Intimate Beauty Care

Beauty’s New Self-Care Essential: Intimate Beauty Care

The subject of intimate beauty is becoming less intimate—and the market is seeing substantial increases as a result.

At one time, the topic of intimate beauty was considered taboo, and products were limited to mass retail aisles. But the U.S. market started to gain significant momentum in the last few years, and now, against the pandemic backdrop, intimate beauty products are expected to record a 13% increase in 2020, according to Kline’s soon-to-be published Intimate Beauty Care: U.S. Market Assessment and Opportunities. Encompassing bikini care, such as hair removal and ingrown hair prevention products; intimate cleansers, including washes and wipes; and intimate moisturizers, such as personal lubricants and external moisturizers for the intimate area, all product categories are forecast to influence growth.Continue reading

How COVID-19 is Changing Trends Within Antimicrobials in Personal Care

As COVID-19 continues to have a negative impact across the world, the International Monetary Fund (IMF) has predicted the global economy to shrink by nearly 5% in June 20201.9% lower than the decline of 3.0% predicted in April 2020. One of the many industries damaged by the pandemic: personal care. While many personal care products are essential, others are not, along with products for which consumers will make alternate choices. In addition, demand for personal care ingredients will also be impacted, as ingredient demand will closely follow product consumption trends. 

Continue reading

Spotlight on Key Turf & Ornamental Markets: Brazil, Japan, and UAE

Kline’s Professional Turf and Ornamental: Markets for Pesticides and Fertilizers study explores the differences between mature markets in Europe and East Asia/Oceania and developing countries in South America and West Asia

The study highlights three market segments (golf, other lawn care, and nurseries/greenhouses) and the five categories (herbicides, insecticides, fungicides, biopesticides, and biostimulants), and is scheduled to be published soon. In this blog, we highlight some of the report’s insights, with a focus on Brazil, Japan, and UAE. Our next blog will cover the other countries included in the study, Australia and Italy. So, keep an eye on our website’s blogs section: https://klinegroup.com/category/agspecialty-pesticides/. 

Continue reading

sustainability in chemicals industry

Drivers for Sustainability in the Chemicals Industry

In more recent times, there has been a push toward developing renewable energy sources, carbon-neutral initiatives, and an integrated life-cycle that would develop and implement digitalization strategies to enable carbon reduction and accountability. The chemicals industry has been at the forefront of innovation, developing chemicals and materials to enable breakthrough technologies and the transition to a low-carbon economy.Continue reading

Will Japan and Europe Switch Activity Impact the U.S. Market?

Embracing Rx-to-OTC Switch: Japan and Europe foster access to nonprescription medications, but will that have an impact on the United States market?

Recently, in Europe and Japan there have been increased Rx-to-OTC switch approvals and an environment fostering switch. The OTC men’s health category is growing in Europe, with the switch approval of Recordati’s Fortacin (lidocaine 7.5mg/prilocaine 2.5 mg) spray for premature ejaculation, via the centralized switch procedure through the European Medicines Agency. This drug marks the fifth medicine approved for switch through this centralized regulatory body, and it is expected to be launched throughout the EU on a nonprescription basis by early 2021. 

Continue reading